Glucose dilates renal afferent arterioles via glucose transporter-1

被引:9
|
作者
Zhang, Jie [1 ]
Jiang, Shan [1 ,2 ]
Wei, Jin [1 ]
Yip, Kay-Pong [1 ]
Wang, Lei [1 ]
Lai, En Yin [2 ]
Liu, Ruisheng [1 ]
机构
[1] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, 12901 Bruce B Downs Blvd MDC 8, Tampa, FL 33612 USA
[2] Zhejiang Univ, Sch Med, Dept Physiol, Hangzhou, Zhejiang, Peoples R China
关键词
afferent arteriole; nitric oxide; NITRIC-OXIDE SYNTHASE; SALT-SENSITIVE HYPERTENSION; DEPENDENT DIABETES-MELLITUS; AORTIC ENDOTHELIAL-CELLS; GLOMERULAR HYPERFILTRATION; TUBULOGLOMERULAR FEEDBACK; FRUCTOSE TRANSPORTER; OXIDATIVE STRESS; KIDNEY-DISEASE; RENIN RELEASE;
D O I
10.1152/ajprenal.00409.2017
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Glomerular hyperfiltration occurs during the early stage of diabetes. An acute glucose infusion increases glomerular filtration rate. The involvement of tubuloglomerular feedback response and direct effect of glucose on the afferent arterioles (Af-Arts) have been suggested. However, the signaling pathways to trigger Af-Art dilatation have not been fully identified. Therefore, in the present study we tested our hypothesis that an increase in glucose concentration enhances endothelial nitric oxide synthesis activity and dilates the Af-Arts via glucose transporter-1 (GLUT1) using isolated mouse Af-Arts with perfusion. We isolated and microperfused the Af-Arts from nondiabetic C57BL/6 mice. The Af-Arts were preconstricted with norepinephrine (1 mu M). When we switched the D-glucose concentration from low (5 mM) to high (30 mM) in the perfusate, the preconstricted Af-Arts significantly dilated by 37.8 +/- 7.1%, but L-glucose did not trigger the dilation. GLUT1 mRNA was identified in microdisserted Af-Arts measured by RT-PCR. Changes in nitric oxide (NO) production in Af-Art were also measured using fluorescent probe when ambient glucose concentration was increased. When the D-glucose concentration was switched from 5 to 30 mM, NO generation in Af-Art was significantly increased by 19.2 +/- 6.2% (84.7 +/- 4.1 to 101.0 +/- 9.3 U/min). L-Glucose had no effect on the NO generation. The GLUT1-selective antagonist 4-[({[4-(1,1-Dimethylethyl)phenyl]sulfonyl}amino)methyl]-N-3-pyridinylbenzamide and the nitric oxide synthase inhibitor N-G-nitro-Larginine methyl ester blocked the high glucose-induced NO generation and vasodilation. In conclusion, we demonstrated that an increase in glucose concentration dilates the Af-Art by stimulation of the endothelium-derived NO production mediated by GLUT1.
引用
收藏
页码:F123 / F129
页数:7
相关论文
共 50 条
  • [31] Gene therapy for a mouse model of glucose transporter-1 deficiency syndrome
    Nakamura, Sachie
    Osaka, Hitoshi
    Muramatsu, Shin-ichi
    Takino, Naomi
    Ito, Mika
    Aoki, Shiho
    Jimbo, Eriko F.
    Shimazaki, Kuniko
    Onaka, Tatsushi
    Ohtsuki, Sumio
    Terasaki, Tetsuya
    Yamagata, Takanori
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2017, 10 : 67 - 74
  • [32] N-glycosylation of glucose transporter-1 (Glut-1) is associated with increased transporter affinity for glucose in human leukemic cells
    Ahmed, N
    Berridge, MV
    LEUKEMIA RESEARCH, 1999, 23 (04) : 395 - 401
  • [33] Variability in glucose transporter-1 levels and hexokinase activity in human melanoma
    Wachsberger, PR
    Gressen, EL
    Bhala, A
    Bobyock, SB
    Storck, C
    Coss, RA
    Berd, D
    Leeper, DB
    MELANOMA RESEARCH, 2002, 12 (01) : 35 - 43
  • [34] Gene Therapy for a Mouse Model of Glucose Transporter-1 Deficiency Syndrome
    Nakamura, Sachie
    Osaka, Hitoshi
    Muramatsu, Shin-ichi
    Takino, Naomi
    Ito, Mika
    Aoki, Shiho
    Jimbo, Eriko F.
    Shimazaki, Kuniko
    Onaka, Tatsushi
    Ohtsuki, Sumio
    Terasaki, Tetsuya
    Yamagata, Takanori
    MOLECULAR THERAPY, 2017, 25 (05) : 108 - 108
  • [35] Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis
    Ozbudak, Irem H.
    Shilo, Konstantin
    Tavora, Fabio
    Rassaei, Negar
    Chu, Wei-Sing
    Fukuoka, Junya
    Jen, Jin
    Travis, William D.
    Franks, Teri J.
    MODERN PATHOLOGY, 2009, 22 (05) : 633 - 638
  • [36] Acute increase, stimulated by prostaglandin E2, in glucose absorption via the sodium dependent glucose transporter-1 in rat intestine
    Scholtka, B
    Stümpel, F
    Jungermann, K
    GUT, 1999, 44 (04) : 490 - 496
  • [37] Immunohistochemical expression of glucose transporter-1 in human penile proliferative lesions
    Moriyama, N
    Kurimoto, S
    Kawabe, K
    Takata, K
    Hirano, H
    HISTOCHEMICAL JOURNAL, 1997, 29 (04): : 273 - 278
  • [38] Immunohistochemical expression of glucose transporter-1 in human penile proliferative lesions
    Nobuo Moriyama
    Shigeharu Kurimoto
    Kazuki Kawabe
    Kuniaki Takata
    Hiroshi Hirano
    The Histochemical Journal, 1997, 29 : 273 - 278
  • [39] Teaching NeuroImage: Fasting EEG in Glucose Transporter-1 Deficiency Syndrome
    Imtiaz, Hassan
    Can, Afra
    Tapos, Daniela
    Weber, Amanda
    NEUROLOGY, 2022, 98 (07) : E774 - E775
  • [40] Predicting response to neoadjuvant therapy with glucose transporter-1 in breast cancer
    Ozturk, Seda Duman
    Ozturk, Cigdem
    Okcu, Oguzhan
    Askan, Gokce
    Sen, Bayram
    Bedir, Recep
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (03): : 440 - 446